Description:
Genova Diagnostics Comprehensive Cardiovascular Profile 2.0 provides state of the art assessment of cardiovascular risk and response to treatment. Utilizing VAP lipid fractionazation technology, physicians can increase their detection of cardiovascular disease risk from 55% with standard lipid profiles to greater than 85% with this test. Inclusion of lipid-independent risk factors such as homocysteine, hs C-reactive protein, and fibrinogen provides effective means to assess methylation impairments, inflammation, and hemostatic factors that relate strongly to cardiovascular disease. Blood draw required, small fee may apply.You receive the results.